Nodal Status, Not Tumor Response to Neoadjuvant Radiation, Determines Outcomes for Patients with Esophageal Cancer


Objective: The CROSS trial established the role of neoadjuvant radiation in the treatment of esophageal adenocarcinoma (EAC). While radiation response is an important factor in predicting long-term outcomes, the vast majority... [ view full abstract ]


  1. Sushanth Reddy (University of Alabama - Birmingham)
  2. Robert Cerfolio (University of Alabama at Birmingham)
  3. Daniel Partain (Mayo Clinic)
  4. Mary Glenn (University of Alabama at Birmingham)
  5. Jacob Swords (University of Alabama at Birmingham)
  6. Carlo Contreras (University of Alabama - Birmingham)
  7. Martin Heslin (University Of Alabama, Surgery)
  8. Thomas Wang (University of Alabama - Birmingham)

Topic Area

Surgical Oncology


QS-SurgOnc » Quick-Shot Presentations: Surgical Oncology (15:00 - Thursday, 21st September, Lee 404)